ResistancePlus® GC receives CE-IVD mark
SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually...
SpeeDx Pty. Ltd. announced today it has received CE-IVD marking for its ResistancePlus® GC assay that detects both the sexually...
Dr. Maria Trent, a Professor of Pediatrics and Public Health at Johns Hopkins Medicine, is spearheading efforts to raise awareness...
SpeeDx have signed of a further four distribution partners, in preparation to strengthen representation across Europe. Axonlab (Germany, Benelux and...
Updated Draft BASHH guidelines on the management of gonorrhoea indicate ciprofloxacin as preferential treatment over ceftriaxone if susceptibility is known. ResistancePlus®...
SpeeDx announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG. "This test is an exciting...
The British Association of Sexual Health and HIV (BASHH) draft guidelines for Mycoplasma genitalium (Mgen) were posted for consultation and...